This page will host Events plug-in for all Clarion and trade events.

Recent Quotes
My Watchlist
Indicators
EL&P Market Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

TG Therapeutics, Inc. - Common Stock (NQ:TGTX)

29.73 +1.86 (+6.67%)
Streaming Delayed Price Updated: 11:38 AM EST, Jan 14, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 4,737,349
Open 31.16
Bid (Size) 29.70 (500)
Ask (Size) 29.77 (600)
Prev. Close 27.87
Today's Range 29.16 - 33.24
52wk Range 25.28 - 46.48
Shares Outstanding 154,420,772
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Retail Traders Are Piling Into TG Therapeutics – What’s Driving The Chatter? ↗
On Tuesday, the company provided the revenue outlook for 2026 and fourth-quarter (Q4) and fiscal year 2025 revenue projection for BRIUMVI. 
Via Stocktwits
Topics Artificial Intelligence
News headline image
TGTX Rallies 7% After Hours On Revenue Estimates Based On Strong Briumvi Demand Through 2026 ↗
The company expects total revenue for full year 2025 to be about $616 million, including $594 million from sales of its Briumvi in the U.S. 
Via Stocktwits
Topics Artificial Intelligence

Performance

YTD
+1.5%
+1.5%
1 Month
-5.3%
-5.3%
3 Month
-12.9%
-12.9%
6 Month
-21.7%
-21.7%
1 Year
+7.4%
+7.4%

More News

Read More
These stocks are moving in today's after hours session ↗
Via Chartmill
News headline image
TG Therapeutics TGTX Q3 2025 Earnings Transcript ↗
Via The Motley Fool
TG Therapeutics Stock Soars After Company Ups Guidance For Multiple Sclerosis Drug ↗
Via Stocktwits
News headline image
Earnings Scheduled For November 3, 2025 ↗
Via Benzinga
News headline image
Earnings Preview For TG Therapeutics ↗
Via Benzinga
TG Therapeutics Board Authorizes New $100M Share Repurchase Program ↗
Via Stocktwits
News headline image
10 Health Care Stocks With Whale Alerts In Today's Session ↗
Via Benzinga
News headline image
TG Therapeutics Crumbles After Roche Unveils Its 'Unprecedented' Test Results ↗
Via Investor's Business Daily
News headline image
Hussman Sells Off All 21,000 CHKP Shares Valued At $4.65 Million ↗
Via The Motley Fool
News headline image
10 Health Care Stocks Whale Activity In Today's Session ↗
Via Benzinga
News headline image
Top Stocks With Earnings This Week: Joby, IonQ, AMD and More ↗
Via Benzinga
News headline image
Highly Watched TG Therapeutics Smashes Profit Views — With A Caveat ↗
Via Investor's Business Daily
Topics Earnings
News headline image
Small-Cap Biotech Climb Bio's Lead Drug Candidate Has Larger Long-Term Opportunity ↗
Via Benzinga
News headline image
TG THERAPEUTICS INC (NASDAQ:TGTX) Shows High Growth Momentum and Technical Breakout Setup ↗
Via Chartmill
News headline image
10 Health Care Stocks Whale Activity In Today's Session ↗
Via Benzinga
News headline image
TG Therapeutics CEO Voices Strong Conviction In Briumvi With New $100 Million Buyback ↗
Via Benzinga
News headline image
TG Therapeutics Stock Tumbles 15% After Disappointing Q2, But Company Reaffirms Confidence In Multiple Sclerosis Drug ↗
Via Stocktwits
Topics Earnings
News headline image
Crude Oil Falls 1.5%; ON Semiconductor Shares Plunge After Q2 Results ↗
Via Benzinga
News headline image
Briumvi's Strong Sales Can't Stop TG Therapeutics Stock Slide ↗
Via Benzinga
News headline image
TG Therapeutics Q2 Revenue Up 91% ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
Why Top 3% Stock TG Therapeutics Crashed Despite Raising Its 2025 Outlook ↗
Via Investor's Business Daily
News headline image
Traders are paying attention to the gapping stocks in Monday's session. ↗
Via Chartmill
News headline image
TG Therapeutics Inc (NASDAQ:TGTX) Reports Mixed Q2 2025 Results, Raises Full-Year BRIUMVI Revenue Guidance ↗
Via Chartmill

Frequently Asked Questions

Is TG Therapeutics, Inc. - Common Stock publicly traded?
Yes, TG Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does TG Therapeutics, Inc. - Common Stock trade on?
TG Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for TG Therapeutics, Inc. - Common Stock?
The ticker symbol for TG Therapeutics, Inc. - Common Stock is TGTX on the Nasdaq Stock Market
What is the current price of TG Therapeutics, Inc. - Common Stock?
The current price of TG Therapeutics, Inc. - Common Stock is 29.73
When was TG Therapeutics, Inc. - Common Stock last traded?
The last trade of TG Therapeutics, Inc. - Common Stock was at 01/14/26 11:38 AM ET
What is the market capitalization of TG Therapeutics, Inc. - Common Stock?
The market capitalization of TG Therapeutics, Inc. - Common Stock is 4.59B
How many shares of TG Therapeutics, Inc. - Common Stock are outstanding?
TG Therapeutics, Inc. - Common Stock has 5B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.